Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Bullfrog AI Holdings Inc. (BFRG) Stock Forecast & Price Prediction United States | NASDAQ | Healthcare | Health Information Services
$0.64
+0.02 (3.35%)Did BFRG Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Bullfrog AI is one of their latest high-conviction picks.
BFRG has shown a year-to-date change of -27.3% and a 1-year change of -63.2%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for BFRG. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for BFRG.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jul 26, 2021 | Bernstein | Market Perform | Upgrade | $N/A |
The following stocks are similar to Bullfrog AI based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Bullfrog AI Holdings Inc. has a market capitalization of $11.84M with a P/E ratio of -1.0x. The company generates $116,670 in trailing twelve-month revenue with a 18.8% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of -5,652.4% and return on equity of -183.0%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Develops AI-driven solutions for biopharmaceuticals.
The company utilizes artificial intelligence and machine learning to process complex medical data, enabling biotechnology and pharmaceutical companies to optimize drug development and clinical trials. Its primary revenue streams come from providing subscription-based access to its platforms, including bfLEAP, bfPREP, and bfARENAS, which streamline data analysis and enhance decision-making in R&D.
Founded in 2017 and based in Gaithersburg, Maryland, the company focuses on precision medicine and has applications in areas like pancreatic cancer analytics. Its innovative tools aim to uncover treatment-effect heterogeneity and biomarkers, positioning it at the cutting edge of computational biology and AI integration.
Healthcare
Health Information Services
9
Mr. Vininder Singh
United States
2023
BullFrog AI Holdings, Inc. has appointed new leaders in commercial technology sales and scientific fields to enhance its growth strategy in AI-driven biomedical insights.
BullFrog AI's leadership changes signal a focus on commercial growth, potentially enhancing revenue and market position, which could positively impact stock performance.
BullFrog AI Holdings, Inc. (NASDAQ: BFRG) has regained compliance with Nasdaq's minimum stockholders' equity requirement, as confirmed by a notice from Nasdaq.
BullFrog AI's compliance with Nasdaq's equity requirements enhances its financial stability, potentially boosting investor confidence and stock performance.
BullFrog AI will showcase its end-to-end drug discovery and development workflow at booth 2957, offering insights into its innovative processes.
BullFrog AI's presentation on drug discovery could signal advancements in biotech, potentially impacting stock prices and investment opportunities in the pharmaceutical sector.
BullFrog AI Holdings, Inc. (Nasdaq: BFRG; BFRGW) reports it is well-capitalized and at commercial stage, engaging with key pharmaceutical and biotech firms as of Q2 2026.
BullFrog AI's strong financial position and commercial progress indicate potential growth, attracting interest from pharmaceutical partners, which could enhance revenue and shareholder value.
Bullfrog AI Inc (BFRG) surged over 100% on Mar. 30 after securing a commercial agreement with a major pharma company to use its bfLEAPยฎ platform for drug discovery in Major Depressive Disorder.
Bullfrog AI's stock surge reflects strong market validation of its technology, potentially attracting further partnerships and investments in the biotech sector, influencing investor sentiment positively.
Bullfrog AI Holdings (NASDAQ:BFRG) shares surged 134% to $1.19 following a commercial agreement with a major pharmaceutical company to utilize its bfLEAP platform for drug target identification in depression.
The surge in Bullfrog AI's shares indicates strong market confidence following a significant partnership, potentially enhancing revenue and growth prospects in the biotech sector.
Analyst forecasts for Bullfrog AI Holdings Inc. (BFRG) are not currently available. The stock is trading at $0.64.
Analyst ratings for BFRG are not currently available. The stock is currently trading at $0.64. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for BFRG are not currently available. The stock is trading at $0.64.
The company utilizes artificial intelligence and machine learning to process complex medical data, enabling biotechnology and pharmaceutical companies to optimize drug development and clinical trials. Its primary revenue streams come from providing subscription-based access to its platforms, including bfLEAP, bfPREP, and bfARENAS, which streamline data analysis and enhance decision-making in R&D.
Price targets from Wall Street analysts for BFRG are not currently available. The stock is trading at $0.64.
Price targets from Wall Street analysts for BFRG are not currently available. The stock is trading at $0.64.
Analyst ratings for BFRG are not currently available. The stock is trading at $0.64.
Stock price projections, including those for Bullfrog AI Holdings Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.